# Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

> **NCT00451646** · PHASE3 · COMPLETED · sponsor: **Fresenius Kabi** · enrollment: 75 (actual)

## Conditions studied

- Parenteral Nutrition

## Interventions

- **DRUG:** SMOF lipid and Intralipid

## Key facts

- **NCT ID:** NCT00451646
- **Lead sponsor:** Fresenius Kabi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00451646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00451646, "Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00451646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*